Sort
17,828 grants matching “crispr”
Project 1. Gene Variants and Their Interactions Defining Human NTD Risk
$565,269Margaret Elizabeth Ross · Weill Medical Coll Of Cornell Univ · P01 · FY2019 · HD
Project 2 - Host-virus networks regulating flu replication and host responses ex vivo
$565,258Sumit K Chanda · Icahn School Of Medicine At Mount Sinai · U19 · FY2019 · AI
Launching HBV with RNA to assess antiviral resistance and explore fundamental aspects of virus-host biology
$565,164Charles M. Rice · Rockefeller University · R01 · FY2021 · AI
Prostate Cancer Risk Enhancers
$564,927Peggy J Farnham · University Of Southern California · R01 · FY2016 · CA
Zfp423 Mechanisms in Joubert Syndrome and Related Disorders
$564,854Bruce A Hamilton · University Of California, San Diego · R01 · FY2025 · NS
CRISPR-induced cardiovascular progenitor cells to repair myocardial infarction
$564,836Yigang Wang · University Of Cincinnati · R01 · FY2024 · HL
Down Syndrome: a potential treatment XISTs
$564,755Volney L Sheen · Beth Israel Deaconess Medical Center · R01 · FY2025 · HD
Study of a new driver and therapeutic vulnerability of bone metastasis
$564,695Li Ma · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
DNA repair alterations in metastatic prostate cancer: functional and therapeutic implications
$564,655Alan Ashworth · University Of California, San Francisco · R01 · FY2018 · CA
Therapeutics for the chorioretina
$564,577Sofia P Becerra · National Eye Institute · ZIA · FY2019 · EY
Regulation of Vascular Integrity
$564,282Brant Weinstein · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2021 · HD
Systematic Functional Interpretation of Regulatory Variants in Schizophrenia
$564,209Jubao Duan · Endeavor Health Clinical Operations · R01 · FY2016 · MH
Reverse Sensitivity Analysis for Identifying Predictive Proteomics Signatures of Cancer
$564,140H. Steven Wiley · Battelle Pacific Northwest Laboratories · U01 · FY2023 · CA
Discovery of Somatic Noncoding Variants that Serve as Drivers in Pediatric Cancers
$564,115Jinghui Zhang · St. Jude Children'S Research Hospital · R01 · FY2020 · CA
Discovery of Somatic Noncoding Variants that Serve as Drivers in Pediatric Cancers
$564,115Jinghui Zhang · St. Jude Children'S Research Hospital · R01 · FY2021 · CA
Regulatory Roles and Dynamics of Nuclear long-noncoding RNAs in Pluripotency
$564,112John Louis Rinn · Harvard University · P01 · FY2017 · GM
Understanding druggable drivers of meningioma tumorigenesis
$563,919David R Raleigh · University Of California, San Francisco · R01 · FY2022 · CA
Understanding druggable drivers of meningioma tumorigenesis
$563,919David R Raleigh · University Of California, San Francisco · R01 · FY2025 · CA
Targeting the mutant promoter of Telomerase Reverse Transcriptase (TERT)
$563,904Dan Theodorescu · Cedars-Sinai Medical Center · R01 · FY2024 · CA
Development of novel protein-based therapeutics for lung cancer
$563,856Eric Alejandro Sweet-Cordero · University Of California, San Francisco · R01 · FY2021 · CA
Development and characterization of mouse models of RP59 DHDDS deficiency
$563,818Steven J Pittler · University Of Alabama At Birmingham · R01 · FY2018 · EY
A Systems Approach to Mapping the DNA Damage Response
$563,619Trey Ideker · University Of California, San Diego · R01 · FY2019 · ES
Project 1 Mouse Models Analysis
$563,617Edgar G. Engleman · Stanford University · U54 · FY2023 · CA
Unconventional protein secretion-mediated protein quality control in health and diseases
$563,420Yihong Ye · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK
Development of novel protein-based therapeutics for lung cancer
$563,401Eric Alejandro Sweet-Cordero · University Of California, San Francisco · R01 · FY2020 · CA